SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001299933-10-000964
Filing Date
2010-03-05
Accepted
2010-03-05 16:22:56
Documents
3
Period of Report
2010-03-02
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_36635.htm 8-K 12463
2 EX-10.1 exhibit1.htm EX-10.1 3240
3 EX-99.1 exhibit2.htm EX-99.1 2769
  Complete submission text file 0001299933-10-000964.txt   20139
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 10661015
SIC: 2836 Biological Products, (No Diagnostic Substances)